• Scientists Hack A Computer Using DNA

    MIT Technology Review | In what appears to be the first successful hack of a software program using DNA, researchers say malware they incorporated into a genetic molecule allowed them to take control of a computer used to analyze it.

    Aug 10, 2017

  • After A Comeback 23andMe Faces Its Next Test

    Fast Company | Can the pioneering DNA-testing company satisfy the FDA while also staying true to its founding mission: putting people in control of their healthcare?

    Aug 9, 2017

  • NIH Accelerates The Use Of Genomics In Clinical Care

    Bio-IT World Brief | The National Institutes of Health is awarding $18.9 million towards research that aims to accelerate the use of genome sequencing in clinical care.

    Aug 8, 2017

  • 4 Key Reasons The Mitalipov Paper Doesn't Herald Safe CRISPR Human Genetic Modification

    The Niche | In Knoepfler lab's stem cell blog breaks down how the media's coverage of recent CRISPR news has been "too rosy and simplistic." The reality, Paul Knoepfler's team argues, is more complicated. There are overlooked technical reasons why the Mitalipov CRISPR human embryo paper is unlikely to herald safe human genetic modification.

    Aug 8, 2017

  • DDN, Gatan Partner On Storage To Handle Microscopy Workflows

    Bio-IT World News Brief  DataDirect Networks has announced a strategic partnership with Gatan to deliver groundbreaking solutions for microscopy research environments and workflows. The DDN and Gatan partnership will combine DDN’s high-performance data storage platform with Gatan’s high-performance cameras to fully leverage the power of the latest technologies in electron microscopy.

    Aug 7, 2017

  • Shkreli is convicted of fraud. Can pharma finally slam the door on him?

    STAT | Martin Shrkeli, convicted of fraud on Friday, has been vilified as a price gouger by politicians, the public, and his fellow biopharma execs. What's next?

    Aug 4, 2017

  • Veritas Buys Curoverse to Bring A.I. Analysis of Genes to the Masses

    Xconomy | Some answers to questions about the risk of developing a disease or a bad reaction to a drug can be found by analyzing a patient's genes. In the not-too-distant future, such queries could be as easy as searching for and selecting a movie on Netflix, contends Rodrigo Martinez, chief marketing and design officer for Veritas Genetics.

    Aug 3, 2017

  • Novogene Doubles Its Fleet Of PacBio Sequencers

    Bio-IT World Brief | Yesterday Pacific Biosciences announced that Novogene had agreed to purchase 10 Sequel Systems, giving the DNA sequencing service provider the capacity to run up to 20 Sequel Systems at a time.

    Aug 3, 2017

  • CRISPR Fixes Disease Gene In Viable Human Embryos

    Bio-IT World Brief | An international team of researchers has used CRISPR–Cas9 gene editing to correct a disease-causing mutation in dozens of viable human embryos.

    Aug 2, 2017

  • Edico Genome Announces Contracts With NHGRI, NCI

    Bio-IT World Brief | Edico Genome today announced it has signed contracts with the National Human Genome Research Institute and the National Cancer Institute for the use of its DRAGEN Bio-IT platform.

    Aug 2, 2017

  • Bright Computing Supports Fayetteville State University In AI Research

    Bio-IT World Brief | Bright Computing announced it has supplied its Bright Cluster Manager solution to Fayetteville State University for use in ground-breaking Artificial Intelligence (AI) research.

    Aug 2, 2017

  • Bioinformatics vs Computational Biology

    Diamond Age Data Science | The world of quantitative biology is large, diffuse and sometimes overwhelming. It's hard sometimes to even figure out what someone means when they say "bioinformatics". This can make it hard to figure out what part of the field someone works in.

    Aug 1, 2017

  • PerkinElmer, Thermo Scientific, Bioz, And More: News From July 2017

    Bio-IT World Brief | July featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including PerkinElmer, Thermo Scientific, Bioz, and more.

    Jul 31, 2017

  • DataCamp Nabs $4M For Data Science Courses, Moves To NY

    Xconomy | DataCamp, which recently raised $4 million from investors, is in the process of moving out of its Boston-area office and relocating to a recently opened headquarters in New York.

    Jul 28, 2017

  • Mark Zuckerberg, Priscilla Chan Donate $10M to Advance Health Using Big Data

    UC San Francisco | Atul Butte, who is helping to guide UCSF into a new era of computational science and medicine, has been named the Priscilla Chan and Mark Zuckerberg Distinguished Professor at UCSF.

    Jul 28, 2017

  • Takeda And Schrödinger Team Up For Drug Discovery

    Asian Scientist Magazine | To leverage each other's strengths and accelerate the drug discovery process, Takeda Pharmaceutical Company Limited has teamed up with Schrödinger Incorporated. The multi-target research collaboration is directed at treating diseases that are aligned with Takeda's core therapeutic areas of interest.

    Jul 27, 2017

  • Pharma Companies Reshape Focus In R&D

    Bio-IT World Brief | Rare diseases have found themselves on the chopping block after a spate of pharma reorganizations.

    Jul 27, 2017

  • First Human Embryos Edited in U.S.

    MIT Technology Review | Researchers have demonstrated they can efficiently improve the DNA of human embryos.

    Jul 27, 2017

  • Merck’s Cyberattack And Biopharma’s Rising Interest In Cybersecurity

    Bio-IT World | Cybersecurity has hardly been biopharma’s main focus, but it demands attention given the volume of collaborations, the varying levels of security each partner maintains, the widespread use of personal devices to access a sponsor’s system, and the importance of protecting a company’s most precious intellectual property—its data.

    Jul 26, 2017

  • Dont run biomedical science as a business

    Nature News & Comment | Science should abandon its assembly-line mentality and rebuild for quality, not quantity, argues Michele Pagano.

    Jul 25, 2017